You just read:

Teysuno™ (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer

News provided by

Taiho Pharmaceutical Co., Ltd.

Dec 17, 2010, 07:41 EST